Comprehensive genomic analysis of circulating tumor DNA for patients with advanced non-small cell lung cancer

被引：4
作者：
Lissa, Delphine [1 ]
Robles, Ana I. [2 ]
机构：
[1] NCI, Lab Human Carcinogenesis, NIH, Bethesda, MD 20892 USA
[2] NCI, Off Canc Clin Prote Res, NIH, Bethesda, MD 20892 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 05期
关键词：
D O I：
10.21037/atm.2018.12.57
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA
    Yaung, Stephanie J.
    Woestmann, Corinna
    Ju, Christine
    Ma, Xiaoju Max
    Gattam, Sandeep
    Zhou, Yiyong
    Xi, Liu
    Pal, Subrata
    Balasubramanyam, Aarthi
    Tikoo, Nalin
    Heussel, Claus Peter
    Thomas, Michael
    Kriegsmann, Mark
    Meister, Michael
    Schneider, Marc A.
    Herth, Felix J.
    Wehnl, Birgit
    Diehn, Maximilian
    Alizadeh, Ash A.
    Palma, John F.
    Muley, Thomas
    CANCERS, 2022, 14 (10)
  • [22] Quantification of Mutant Alleles in Circulating Tumor DNA from Advanced Non-Small Cell Lung Cancer
    Wang, Jie
    Yang, Xue
    Zhuo, Minglei
    Ye, Xin
    Bai, Hua
    Wang, Zhijie
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S205 - S205
  • [23] Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
    Yanjun Xu
    Zhiyu Huang
    Xiaoqing Yu
    Kaiyan Chen
    Yun Fan
    Molecular Brain, 14
  • [24] Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
    Xu, Yanjun
    Huang, Zhiyu
    Yu, Xiaoqing
    Chen, Kaiyan
    Fan, Yun
    MOLECULAR BRAIN, 2021, 14 (01)
  • [25] Circulating Tumor DNA Assay and Survival in Patients with Metastatic, Non-Small Cell Lung Cancer
    Ersek, J.
    Hosking, M.
    Symanowski, J.
    Green, E.
    Zhang, Q.
    Kim, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S663 - S664
  • [26] Possible application of circulating free tumor DNA in non-small cell lung cancer patients
    Karachaliou, Niki
    Sosa, Aaron E.
    Angel Molina, Miguel
    Centelles Ruiz, Margarita
    Rosell, Rafael
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1364 - S1372
  • [27] Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients
    Paul van der Leest
    Pim Rozendal
    Naomi Rifaela
    Anthonie J. van der Wekken
    Hanneke Kievit
    Vincent D. de Jager
    Grigory Sidorenkov
    Léon C. van Kempen
    T. Jeroen N. Hiltermann
    Ed Schuuring
    Communications Medicine, 5 (1):
  • [28] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Circulating Tumor DNA as a Biomarker in Oligometastatic Non-small Cell Lung Cancer
    Lebow, E. S.
    Murciano-Goroff, Y.
    Razavi, P.
    Reis-Filho, J. S.
    Flynn, J.
    Zhang, Z.
    Tu, H. Y.
    Bertucci, C.
    Lim, L. P.
    Li, M.
    Drilon, A.
    Riely, G.
    Rudin, C. M.
    Jones, D.
    Yang, T. J.
    Rimner, A.
    Arcila, M. E.
    Isbell, J.
    Li, B. T.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S174 - S174
  • [30] Use of comprehensive cell free circuating tumor DNA (cfDNA) analysis to identify genomic biomarkers in newly diagnosed advanced non-small cell lung cancer (NSCLC) patients
    Palmero, Ramon
    Taus, Alvaro
    Viteri, Santiago
    Majem, Margarita
    Carcereny, Enric
    Garde, Javier
    Felip, Enriqueta
    Gomez, Lourdes
    Malfettone, Andrea
    Sampayo, Miguel
    Lopez, Noemi
    Nagy, Rebecca
    Jackson, Matthew
    Faull, Iris
    Dix, Daniel
    Karachaliou, Niki
    Rosell, Rafael
    CANCER RESEARCH, 2019, 79 (13)
12345